Financial Gravity Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Financial Gravity Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-540	Closed	-$2.67K	–	887
2022 Q2	$2.67K	Buy	+540	New	+$14.6K	0.08%	236
2021 Q2	–	Sell	-144	Closed	-$3.77K	–	1035
2021 Q1	$3.77K	Buy	144 +42	+41%	+$999	0.08%	170
2020 Q4	$2K	Buy	+102	New	+$1.91K	﹤0.01%	359
2019 Q4	–	Sell	-678	Closed	-$6K	–	1774
2019 Q3	$6K	Sell	678 -1,763	-72%	-$18.6K	0.01%	683
2019 Q2	$29K	Buy	+2,441	New	+$29.4K	0.02%	427
2018 Q3	$2K	Sell	101 -340	-77%	-$5.27K	﹤0.01%	1031
2018 Q2	$7K	Buy	441 +228	+107%	+$3.4K	0.01%	670
2018 Q1	$3K	Buy	+213	New	+$3.15K	﹤0.01%	900

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Financial Gravity Asset Management's VIVO Position: Q3 2022 in Review

Financial Gravity Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q3 2022, closing a stake of 540 shares — an estimated $2.67K sold.

Financial Gravity Asset Management first reported a position in VIVO in Q1 2018 and held it in 8 quarters. The position peaked at $29K in Q2 2019. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.

Financial Gravity Asset Management reported no remaining Meridian Bioscience Inc position as of Q3 2022 after selling out during the quarter.
Financial Gravity Asset Management sold 540 Meridian Bioscience Inc shares in Q3 2022, an estimated $2.67K.
Financial Gravity Asset Management first reported a position in Meridian Bioscience Inc in Q1 2018 and held it in 8 quarters.
Financial Gravity Asset Management's Meridian Bioscience Inc position peaked at $29K in Q2 2019.
203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.

Based on Financial Gravity Asset Management's 13F filing for Q3 2022, filed 3 Nov 2022.